The first Evogene Ltd trade was made in Q4 2016.
Since then Cathie Wood bought shares thirteen more times and sold shares on six occasions. The investor completely sold their stake between Q2 2021 and Q1 2022.
Avg closing price
Price range
Sold -361 Thousand shares
Q1 2022
Avg closing price
$1.35
Price range
$1.09
-
$1.83
Sold 10.4% shares (-41.7 Thousand shares)
Q4 2021
Avg closing price
$2.27
Price range
$1.63
-
$2.83
Sold 3.9% shares (-16.4 Thousand shares)
Q3 2021
Avg closing price
$2.92
Price range
$2.45
-
$3.45
Sold 12.6% shares (-60.3 Thousand shares)
Q2 2021
Avg closing price
$3.92
Price range
$3.30
-
$5.02
Increased shares by 4.4% (+20.2 Thousand shares)
Q1 2021
Avg closing price
$6.23
Price range
$4.29
-
$9.94
Sold 0.5% shares (-2.43 Thousand shares)
Q4 2020
Avg closing price
-
Price range
-
-
-
Increased shares by 1068.6% (+422 Thousand shares)
Q3 2020
Avg closing price
-
Price range
-
-
-
Increased shares by 54.3% (+13.9 Thousand shares)
Q2 2020
Avg closing price
-
Price range
-
-
-
Increased shares by 12.7% (+2.89 Thousand shares)
Q1 2020
Avg closing price
-
Price range
-
-
-
Sold 20.8% shares (-5.95 Thousand shares)
Q4 2019
Avg closing price
-
Price range
-
-
-
Increased shares by 13.7% (+3.46 Thousand shares)
Q1 2019
Avg closing price
-
Price range
-
-
-
Increased shares by 3.9% (+955 shares)
Q4 2018
Avg closing price
-
Price range
-
-
-
Increased shares by 45.0% (+7.52 Thousand shares)
Q3 2018
Avg closing price
-
Price range
-
-
-
Increased shares by 169.3% (+10.5 Thousand shares)
Q2 2018
Avg closing price
-
Price range
-
-
-
Increased shares by 97.4% (+3.07 Thousand shares)
Q1 2018
Avg closing price
-
Price range
-
-
-
Increased shares by 53.3% (+1.1 Thousand shares)
Q4 2017